WASHINGTON — Forget the push to bring more generics to market or to tweak Medicare’s arcane payment system.

Democrats, newly empowered in D.C. and on the hunt for bigger and bolder ways to lower drug prices, are suddenly taking aim at a far more central part of pharma’s monopoly power: the patents the industry holds on its drugs.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • The author unfortunately refers to “legislation that could end drug company monopolies,” which is just the sort of hyperbole that PhRMA feeds on. These proposals would not “end” monopolies, but rather regulate the use of — and combat the abuse of — monopolies. As we do in other sectors where monopolies exist. These are sensible proposals that should be debated. The US is virtually the only country that grants the patent (i.e. monopoly) and then allows the patent-holder (monopolist) to charge whatever price it wants.

  • It looks like these journalists/marketers did not look at the latest alternative facts coming from HHS. According to industry insiders at HHS lower pharmaceutical prices lead to socialism. In Alternate Fact America, this kind of market industry fluff continues to add to the death toll, as people die in the Epidemic of Despair.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy